Drug intelligence / Profile preview

Esp protein

Development stage
Unknown
Lead developer
University of British Columbia
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Esp (extracellular serine protease) is a protein secreted by the skin commensal bacterium *Staphylococcus epidermidis* that inhibits the formation and promotes the degradation of *Staphylococcus aureus* biofilms. In chronic wounds like venous leg ulcers, *S. aureus* biofilms create a protective environment for bacteria, contributing to persistent infection, inflammation, and impaired healing. The Esp protein acts as a serine protease that cleaves specific *S. aureus* surface proteins required for biofilm maintenance, thereby disrupting the biofilm structure and making the bacteria more susceptible to the host immune system and antimicrobial treatments. The University of British Columbia is developing this protein as a topical biological therapy to improve healing outcomes in patients with chronic venous leg ulcers.

Other names
Staphylococcus epidermidis Esp proteinExtracellular serine protease
02

Targets

Bap (Biofilm-associated protein)

Beyond the preview

Go deeper on Esp protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esp protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call